Prescient Therapeutics Ltd (PTX) — Cash Flow Reinvestment Rate
Prescient Therapeutics Ltd (PTX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2013, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$32.65K. Explore how much does Prescient Therapeutics Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Prescient Therapeutics Ltd Cash Flow Reinvestment Rate (1991–1993)
Historical reinvestment intensity for Prescient Therapeutics Ltd across 2 annual periods. Also explore Prescient Therapeutics Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Prescient Therapeutics Ltd (1991–1993)
Year-by-year capital reinvestment analysis for Prescient Therapeutics Ltd. For live market cap and broader valuation context, see Prescient Therapeutics Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 1993 | 0.32x | AU$562.00K | AU$1.74 Million | AU$562.00K | ▼ -12.3% |
| 1991 | 0.37x | AU$269.00K | AU$730.00K | AU$269.00K | — |